This map shows the geographic impact of E Schraven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Schraven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Schraven more than expected).
This network shows the impact of papers produced by E Schraven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Schraven. The network helps show where E Schraven may publish in the future.
Co-authorship network of co-authors of E Schraven
This figure shows the co-authorship network connecting the top 25 collaborators of E Schraven.
A scholar is included among the top collaborators of E Schraven based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E Schraven. E Schraven is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Dittrich, P., Jerzy Ostrowski, Eckhard Beubler, E Schraven, & W. R. Kukovetz. (1985). [HPLC determination of troxerutin in plasma and urine following oral administration in man].. PubMed. 35(4). 765–7.4 indexed citations
5.
Schraven, E, et al.. (1984). [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].. PubMed. 34(10). 1258–60.3 indexed citations
Schraven, E, et al.. (1982). Vitamin D-induced myocardial lesions and the protection by carbocromen.. PubMed. 32(11). 1412–7.2 indexed citations
8.
Fromson, J. M., H. Paul A. Illing, R. M. J. Ings, et al.. (1981). Absorption and disposition of [14C]-molsidomine in laboratory animals.. PubMed. 31(2). 337–45.7 indexed citations
9.
Schraven, E. (1978). Influence of carbocromene on free fatty acid metabolism of the heart.. PubMed. 11. 363–7.4 indexed citations
10.
Schraven, E. (1976). [Regulation of lipid and carbohydrate metabolism of the heart by carbocromen (author's transl)].. PubMed. 26(2). 197–200.5 indexed citations
11.
Schraven, E, et al.. (1976). [The effect of carbocromen on cardiac cyclic adenosine-monophosphate].. PubMed. 26(2). 200–4.2 indexed citations
12.
Schraven, E, et al.. (1973). [Site of action of the coronary drug carbocromen].. PubMed. 91(19). 837–43.
13.
Schraven, E, et al.. (1972). [Studies on the distribution of carbochromen- 14 C in rats. Organ distribution and whole-body autoradiography after i.v. administration].. PubMed. 22(3). 479–87.
14.
Scholtholt, J, et al.. (1972). On the mechanism of the antagonistic action of xanthine derivatives against adenosine and coronary vasodilators.. PubMed. 22(8). 1255–9.21 indexed citations
15.
Möllmann, H, et al.. (1972). [Pharmacodynamic studies after short- and long-term treatment with radioactively labelled 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-2-oxo-(1,2-chromene)-hydrochloride in animal experiments].. PubMed. 22(8). 1242–50.
16.
Schraven, E, et al.. (1970). [Blood levels, distribution in the organs and excretion of carbochromen in rat, dog and man].. PubMed. 20(12). 1905–11.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.